Treating recurrent percutaneous transluminal angioplasty (PTA) failure with the GORE® VIABAHN® Endoprosthesis

angiogram

Challenge

  • 72-year-old male with thrombosed left arm arteriovenous (AV) graft
  • Graft was initially placed eight years ago followed by multiple interventions

Image: Thrombosed left arm AV graft. 80% stenosis just past venous anastomosis.
Images courtesy of Jason Burgess, MD. Used with permission.

angiogram

Procedure

  • A percutaneous thrombectomy was performed with the BOSTON SCIENTIFIC ANGIOJET Thrombectomy System
  • The patient was found to have 80% stenosis just past the venous anastomosis
  • Stenosis at the venous anastomosis was treated with balloon angioplasty with immediate recoil of stenosis
  • A GORE® VIABAHN® Endoprosthesis, 7 mm x 5 cm, was then placed across the venous anastomosis

Image: Prior to the placement of a GORE® VIABAHN® Endoprosthesis, balloon angioplasty was performed to predilate the lesion at the venous anastomosis of the graft
Images courtesy of Jason Burgess, MD. Used with permission.

angiogram

Result

  • Excellent angiographic result
  • Thrill restored to the graft

Image: Post placement of 7 mm x 5 cm GORE® VIABAHN® Endoprosthesis
Images courtesy of Jason Burgess, MD. Used with permission.

Case Takeaways

  • The GORE® VIABAHN® Endoprosthesis successfully treated a graft outflow lesion that had failed balloon angioplasty

BOSTON SCIENTIFIC and ANGIOJET are trademarks of Boston Scientific Corporation.

The outcomes and observations reported are based on individual case experience and the patients treated. The steps described here may not be complete, and are not intended to be a replacement for the Instructions for Use or the education, training and professional judgment of Healthcare Providers. Healthcare Providers remain solely responsible for making decisions about patient care and the use of medical technologies. 

Refer to Instructions for Use at eifu.goremedical.com for complete description of all indications, warnings, precautions and contraindications for the markets where this product is available.  

Visit our clinical uses page

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.